A Study of Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

This study is currently recruiting participants.

Study NCT00658567 Information provided by ACADIA Pharmaceuticals Inc.

First Received: April 10, 2008 Last Updated: July 16, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	December 2009 (Final data collection date for primary outcome measure)